MARKET

FBIOP

FBIOP

Fortress Biotech Inc
NASDAQ
12.29
+0.30
+2.50%
Closed 14:25 02/09 EST
OPEN
12.00
PREV CLOSE
11.99
HIGH
12.38
LOW
11.57
VOLUME
6.99K
TURNOVER
0
52 WEEK HIGH
12.98
52 WEEK LOW
4.720
MARKET CAP
42.12M
P/E (TTM)
-41.9454
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FBIOP last week (0202-0206)?
Weekly Report · 1d ago
Weekly Report: what happened at FBIOP last week (0126-0130)?
Weekly Report · 02/02 09:38
Weekly Report: what happened at FBIOP last week (0119-0123)?
Weekly Report · 01/26 09:39
Weekly Report: what happened at FBIOP last week (0112-0116)?
Weekly Report · 01/19 09:42
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 01/13 17:05
BUZZ-U.S. STOCKS ON THE MOVE-Albemarle, Lowe's, nLIGHT
Reuters · 01/13 15:42
FORTRESS BIOTECH SHARES HIT NEAR TWO-WEEK LOW, LAST DOWN 6.6%
Reuters · 01/13 14:46
Cyprium Therapeutics Wins FDA Approval for ZYCUBO in Menkes Disease
Reuters · 01/13 14:20
More
About FBIOP
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has eight marketed prescription pharmaceutical products and over 20 programs in development, with its majority-owned and majority-controlled partners and subsidiaries and partners and subsidiaries it founded and in which it holds significant minority ownership positions. Its portfolio is being commercialized and developed for various therapeutic areas, including oncology, dermatology, and rare diseases. Its dermatology products include Emrosi, Qbrexza, Amzeeq, Zilxi, Exelderm, Targadox, and Luxamend. Its late-stage product candidates include CUTX-101 (copper histidinate injection for Menkes disease), Triplex (cytomegalovirus (CMV) vaccine), and CAEL-101 (monoclonal antibody for AL amyloidosis). Its early and mid-stage product candidates include Dotinurad (urate transporter (URAT1) inhibitor for gout), MB-101 (IL13Rα2 CAR T Cell Program for Glioblastoma), and others.

Webull offers Fortress Biotech Inc stock information, including NASDAQ: FBIOP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBIOP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBIOP stock methods without spending real money on the virtual paper trading platform.